Evidence map›Paper›PMID 40227588›Full record

ArticleCancers2025

Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair Genes.

Maximiliano Ribeiro-Guerra, Marie-Gabrielle Dondon, Séverine Eon-Marchais, Dorothée Le Gal, Juana Beauvallet, Noura Mebirouk, Muriel Belotti, Eve Cavaciuti, Claude Adenis-Lavignasse, Séverine Audebert-Bellanger and 35 more

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors.

Maximiliano Ribeiro-GuerraInserm, U1331, 75248 Paris cedex 05, France.ORCID 0000-0003-0234-7190
Marie-Gabrielle DondonInserm, U1331, 75248 Paris cedex 05, France.ORCID 0000-0001-6016-8524
Séverine Eon-MarchaisInserm, U1331, 75248 Paris cedex 05, France.ORCID 0000-0001-5021-7775
Dorothée Le GalInserm, U1331, 75248 Paris cedex 05, France.ORCID 0009-0008-0595-7676
Juana BeauvalletInserm, U1331, 75248 Paris cedex 05, France.ORCID 0009-0001-0538-263X
Noura MebiroukInserm, U1331, 75248 Paris cedex 05, France.ORCID 0000-0001-5553-9757
Muriel BelottiInstitut Curie, Service de Génétique, 75248 Paris cedex 05, France.
Eve CavaciutiInserm, U1331, 75248 Paris cedex 05, France.ORCID 0000-0001-7086-2149
Claude Adenis-LavignassePolyclinique de la Louvière (Groupe Ramsay), 59800 Lille, France.
Séverine Audebert-BellangerDépartement de Génétique Médicale et Biologie de la Reproduction, Hôpital Morvan, CHU Brest, 29200 Brest, France.
Pascaline BerthetUnité de Pathologie Gynécologique, Centre François Baclesse, 14000 Caen, France.
Valérie BonadonaCNRS, Laboratoire de Biométrie et Biologie Evolutive UMR 5558, Université Lyon 1, 69622 Villeurbanne, France.
Bruno BuecherInstitut Curie, Service de Génétique, 75248 Paris cedex 05, France.
Olivier CaronGustave Roussy, Département de Médecine Oncologique, 94800 Villejuif, France.ORCID 0000-0001-8934-2071
Mathias CavailleCentre Jean Perrin, Département d'Oncogénétique, Inserm, UMR 1240, Université Clermont Auvergne, 63001 Clermont Ferrand, France.ORCID 0000-0002-4079-4891
Jean ChiesaService d'Oncologie Médicale, CHRU Hôpital Caremeau, 30900 Nîmes, France.
Chrystelle ColasInstitut Curie, Service de Génétique, 75248 Paris cedex 05, France.
Isabelle CoupierService de Génétique Médicale et Oncogénétique, Hôpital Arnaud de Villeneuve, CHU Montpellier, 34090 Montpellier, France.
Capucine DelnatteUnité d'Oncogénétique, Institut de Cancérologie de l'Ouest, 44800 Saint-Herblain, France.
Hélène DreyfusClinique Sainte Catherine, 84000 Avignon, France.
Anne FajacService d'Oncogénétique, Hôpital Tenon, 75020 Paris, France.
Sandra Fert-FerrerService de Génétique, Centre Hospitalier Métropole Savoie, 73000 Chambéry, France.
Jean-Pierre FrickerCentre Paul Strauss, Unité d'Oncologie, 67200 Strasbourg, France.ORCID 0000-0002-1210-2317
Marion Gauthier-VillarsInstitut Curie, Service de Génétique, 75248 Paris cedex 05, France.
Paul GestaService d'Oncogénétique Régional Poitou-Charentes, CH Georges Renon, 79000 Niort, France.
Sophie GiraudCentre Hospitalier de la Côte Basque, Institut Bergonié, 33000 Bordeaux, France.
Laurence GladieffService d'Oncologie Médicale, Institut Claudius Regaud, IUCT-Oncopole, 31100 Toulouse, France.ORCID 0000-0002-6980-9719
Christine LassetCNRS, Laboratoire de Biométrie et Biologie Evolutive UMR 5558, Université Lyon 1, 69622 Villeurbanne, France.
Sophie Lejeune-DumoulinClinique de Génétique Médicale Guy Fontaine, CHU Lille, 59000 Lille, France.
Jean-Marc LimacherService d'Onco-Hématologie, Hôpital Pasteur, 68024 Colmar, France.ORCID 0000-0002-7723-5508
Michel LongyCancer Genetics Unit, Inserm U1312, Institut Bergonié, University of Bordeaux, 33000 Bordeaux, France.
Alain LortholaryService d'Oncologie Médicale, Centre Catherine de Sienne, 44200 Nantes, France.
Elisabeth LuporsiService de Génétique, UF4128, CHR Metz-Thionville, Hôpital de Mercy, 57530 Ars-Laquenexy, France.
Christine M MaugardUF1422, Génétique Oncologique Moléculaire, Département d'Oncobiologie, LBBM, Hôpitaux Universitaires de Strasbourg, 67200 Strasbourg, France.
Isabelle MortemousqueService de Génétique, Hôpital Bretonneau, 75018 Paris, France.
Sophie NambotInstitut GIMI, Oncogénétique, CHU de Dijon, Hôpital d'Enfants, 21000 Dijon, France.
Catherine NoguèsDépartement d'Anticipation et de Suivi des Cancers, Oncogénétique Clinique, Institut Paoli-Calmettes, 13009 Marseille, France.
Pascal PujolService de Génétique Médicale et Oncogénétique, Hôpital Arnaud de Villeneuve, CHU Montpellier, 34090 Montpellier, France.ORCID 0000-0001-8315-4715
Laurence Venat-BouvetService d'Oncologie Médicale, Hôpital Universitaire Dupuytren, 87000 Limoges, France.ORCID 0000-0002-0716-2550
Florent SoubrierUMR_S 1166, Faculté de Médecine, SU Site Pitié-Salpêtrière, 75013 Paris, France.
Julie TinatService de Génétique Médicale, CHU De Bordeaux, Groupe Hospitalier Pellegrin, 33000 Bordeaux, France.ORCID 0000-0002-7383-452X
Anne TardivonService de Radiologie, Institut Curie, 75005 Paris, France.
Fabienne LesueurInserm, U1331, 75248 Paris cedex 05, France.ORCID 0000-0001-7404-4549
Dominique Stoppa-LyonnetInstitut Curie, Service de Génétique, 75248 Paris cedex 05, France.
Nadine AndrieuInserm, U1331, 75248 Paris cedex 05, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWomen with a familial predisposition to breast cancer (BC) are offered screening at earlier ages and more frequently than women from the general population.

methodsWe evaluated the effect of screening mammography in 1552 BC cases with a hereditary predisposition to BC unexplained by

resultsOverall, having been exposed to mammograms (never vs. ever) was not associated with BC risk. However, an increase in BC risk of 4% (95% CI: 1-6%) per additional exposure was found under the assumption of linearity. When grouped according to D-PDV carrier status, mammograms doubled the BC risk of women carrying a D-PDV in Group "Reduced", as compared to those carrying a D-PDV in Group "Increased".

conclusionsOur study is the first to investigate the joint effect of mammogram exposure and variants in DNA repair genes other than

Indexed as

breast cancerDNA repair geneshigh-risk populationmammography screening

Identifiers

PMID40227588
PMCPMC11987804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.